Infant 25% DEXTROSE Injection, USP, 2.5 g (250 mg/mL), 10 mL Unit of Use Single-dose Syringe per carton, Rx only, Hospira Inc., Lake Forest, IL 60045, NDC 0409-1775-10
Published May 31, 2017 · Recall initiated: April 21, 2017
Summary
FDA records drug Class I recall D-0862-2017, published May 31, 2017 and initiated April 21, 2017. Recalling firm: Hospira Inc.; Status: Ongoing; Reported quantity: 71,550 syringes; Lot: Lot 58382EV*, Exp 1OCT 2017, *lot may be followed by 01 or 02. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Particulate Matter: human hair found within an internal sample syringe.
What to do
Voluntary: Firm initiated · Press Release
Get an email if DEXTROSE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- DEXTROSE
- Manufacturer
- Hospira Inc.
- Distributor
- Nationwide in the USA and Puerto Rico
- Lot
- Lot 58382EV*, Exp 1OCT 2017, *lot may be followed by 01 or 02
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDADEXTROSE INJECTION USP, 70%, 2000 mL bags, Rx only, Sterile, B. Braun Medical Inc., Bethlehem, PA 18018-3524,April 29, 2026
- FDA5% Dextrose Injection, USP 12.5 g per 250 mL (50 mg per mL) 250 mL in a 250 mL freeflex bag, Fresenius KabiApril 15, 2026
- FDA5% Dextrose Injection, USP 2.5 g per 50 mL (50 mg per mL) 50 mL in a 100 mL freeflex bag, Fresenius Kabi USA,April 15, 2026
- FDA5% Dextrose Injection, USP 5 g per 100 mL (50 mg per mL) 100 mL in a 100 mL freeflex bag, Fresenius Kabi USA,April 15, 2026
- FDANorethindrone Acetate and Ethinyl Estradiol Tablets, USP, 1 mg/0.02 mg, 1 blister pack containing 21 tabletsMay 31, 2017
- FDAHyland's Baby Teething Tablets [Calcarea Phosporica 6X HPUS, Chamomilla 6X HPUS, Coffea Cruda 6X HPUS,May 31, 2017
Questions about this recall
Was Infant 25% DEXTROSE Injection, USP, 2.5 g (250 mg/mL), 10 mL Unit of Use Single-dose Syringe per carton, Rx only, Hospira Inc., Lake Forest, IL 60045, NDC 0409-1775-10 recalled?
Yes. FDA published recall D-0862-2017 on May 31, 2017. Reported hazard: Presence of Particulate Matter: human hair found within an internal sample syringe.
What should I do if I have this product?
Voluntary: Firm initiated · Press Release
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: DEXTROSE.